Systemic lupus erythematosus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) 18 years old and above; (2) Meet the SLE classification standard of the International Lupus Research Clinical Collaborative Group (SLICC) in 2012; (3) Meet the diagnostic criteria of TCM syndrome; (4) The patient knows and agrees to participate in the study.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women (2) Patients with end-stage nephropathy IV heart failure (NYHA grade), liver failure, sepsis, malignant tumors; (3) SLEDAI score > 14 points or frequent SLE activities in the past, and the frequency of medication is adjusted; (4) Those who have been allergic to the drug components used in this research, or are prone to allergies. (If one exclusion criterion is met, it will be excluded)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SLEDAI;Infection incidence; | — |
Secondary
| Measure | Time frame |
|---|---|
| LupusHoL;SLICC/ACR Damage index;TCM certificate waiting points;Hormone dosage;Disease recurrence rate;Anti-dsDNA antibodies and their quantification;Supplement C3;Erythrocyte sedimentation;C-Reactive protein;Lymphocyte subset;Immunoglobulin IgG; | — |
Countries
China
Contacts
Yunnan Provincial Hospital of Traditional Chinese Medicine